Metraipolis › archive › dc_a5e1ff00236a

Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization — arXiv:2611.03844

Source
arXiv (en)
Original
https://arxiv.org/abs/2611.03844
License (as archived)
CC0-1.0
Archived
2026-11-04T18:53:48.590Z
SHA-256 of the archived text
2c529e1bf1cb8b0b075bfcb04aeaaa0c1f4fe51daf70d153340602d3a6e4932a
Stable URL of this page
https://metraipolis.com/documento/dc_a5e1ff00236a

How to cite

Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization — arXiv:2611.03844 — arXiv (en), https://arxiv.org/abs/2611.03844 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a5e1ff00236a (Metraipolis archive dc_a5e1ff00236a, sha256 2c529e1bf1cb8b0b075bfcb04aeaaa0c1f4fe51daf70d153340602d3a6e4932a)
BibTeX
@misc{dca5e1ff00236a,
  title = {Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization — arXiv:2611.03844},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2611.03844},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a5e1ff00236a; sha256 2c529e1bf1cb8b0b075bfcb04aeaaa0c1f4fe51daf70d153340602d3a6e4932a},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2611.03844. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Therapeutic antibody development is often framed as comprising two discrete stages: initial discovery of novel binders followed by iterative optimization to refine these hits into therapeutic-grade molecules. Models and methods often reflect these stages, with generative structure models applied to discovery and probabilistic black-box optimization methods applied to refinement. Here we propose to unify these stages by smoothly transitioning a generative discovery model into iterative optimization, allowing the handoff between the structure-based prior and supervision from wet lab data to be guided by the posterior uncertainty of a probabilistic surrogate. We show that this yields improvements in optimization efficiency in the low-N regime, as well as improved diversity amongst the optimized molecules.

Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.LG, nuovi lavori del giorno).
Categorie arXiv: Machine Learning (cs.LG).
Pagina del lavoro: https://arxiv.org/abs/2611.03844 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-11-04T18:35:37.398Z dalla pagina https://arxiv.org/list/cs.LG/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).